The Interplay of Microbiome and Immune Response in Health and Diseases
[Increasing evidence suggests that microbiota and especially the gut microbiota (the microbes inhabiting the gut including bacteria, archaea, viruses, and fungi) plays a key role in human physiology and pathology. Recent findings indicate how dysbiosis-an imbalance in the composition and organizatio...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Book Chapter |
| Published: |
MDPI - Multidisciplinary Digital Publishing Institute
2019
|
| Subjects: | |
| Online Access: | Get Fullteks DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 04932naaaa2201189uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_50545 | ||
| 005 | 20210211 | ||
| 020 | |a books978-3-03921-647-5 | ||
| 020 | |a 9783039216475 | ||
| 020 | |a 9783039216468 | ||
| 024 | 7 | |a 10.3390/books978-3-03921-647-5 |c doi | |
| 041 | 0 | |a English | |
| 042 | |a dc | ||
| 100 | 1 | |a Barceló-Coblijn, Gwendolyn |4 auth | |
| 700 | 1 | |a Amedei, Amedeo |4 auth | |
| 245 | 1 | 0 | |a The Interplay of Microbiome and Immune Response in Health and Diseases |
| 260 | |b MDPI - Multidisciplinary Digital Publishing Institute |c 2019 | ||
| 300 | |a 1 electronic resource (206 p.) | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a [Increasing evidence suggests that microbiota and especially the gut microbiota (the microbes inhabiting the gut including bacteria, archaea, viruses, and fungi) plays a key role in human physiology and pathology. Recent findings indicate how dysbiosis-an imbalance in the composition and organization of microbial populations-could severely impact the development of different medical conditions (from metabolic to mood disorders), providing new insights into the comprehension of diverse diseases, such as IBD, obesity, asthma, autism, stroke, diabetes, and cancer. Given that microbial cells in the gut outnumber host cells, microbiota influences human physiology both functionally and structurally. Microbial metabolites bridge various-even distant-areas of the organism by way of the immune and hormone system. For instance, it is now clear that the mutual interaction between the gastrointestinal tract and the brain (gut-brain axis), often involves gut microbiota, indicating that the crosstalk between the organism and its microbial residents represents a fundamental aspect of both the establishment and maintenance of healthy conditions. Moreover, it is crucial to recognize that beyond the intestinal tract, microbiota populates other host organs and tissues (e.g., skin and oral mucosa). We have edited this eBook with the aim of publishing manuscripts focusing on the impact of microbiota in the development of different diseases and their associated treatments.] | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by-nc-nd/4.0/ |2 cc |4 https://creativecommons.org/licenses/by-nc-nd/4.0/ | ||
| 546 | |a English | ||
| 653 | |a gastrointestinal diseases | ||
| 653 | |a sterile inflammation | ||
| 653 | |a n/a | ||
| 653 | |a Staphylococcus spp. | ||
| 653 | |a etiopathogenesis | ||
| 653 | |a colitis | ||
| 653 | |a Escherichia coli | ||
| 653 | |a bacteriophages | ||
| 653 | |a atopic dermatitis | ||
| 653 | |a intravenous immunoglobulin G | ||
| 653 | |a adaptive immunity | ||
| 653 | |a 16S rRNA gene | ||
| 653 | |a vaginal microbiota | ||
| 653 | |a modularity | ||
| 653 | |a innate immunity | ||
| 653 | |a gut-liver axis | ||
| 653 | |a disease activity | ||
| 653 | |a immune system | ||
| 653 | |a cytokines | ||
| 653 | |a commensals | ||
| 653 | |a Staphylococcus aureus | ||
| 653 | |a dysbiosis | ||
| 653 | |a fecal transplantation | ||
| 653 | |a TLR mimicry | ||
| 653 | |a etanercept | ||
| 653 | |a dextran sulfate sodium | ||
| 653 | |a CAR T-cell | ||
| 653 | |a 3-dihydroxy-4-methoxyBenzaldehyde | ||
| 653 | |a chemo free treatment | ||
| 653 | |a Staphylococcus epidermis | ||
| 653 | |a rheumatoid arthritis | ||
| 653 | |a microbiome | ||
| 653 | |a co-occurrence network | ||
| 653 | |a immune epigenetics | ||
| 653 | |a 2 | ||
| 653 | |a autoimmunity | ||
| 653 | |a superoxide dismutase | ||
| 653 | |a precision medicine | ||
| 653 | |a metabolism | ||
| 653 | |a adoptive cell transfer (ACT) | ||
| 653 | |a gut barrier | ||
| 653 | |a antibiotics | ||
| 653 | |a checkpoint inhibitors | ||
| 653 | |a probiotics | ||
| 653 | |a microbiota | ||
| 653 | |a Candida albicans | ||
| 653 | |a Enterococcus faecalis | ||
| 653 | |a chronic liver diseases | ||
| 653 | |a TCR | ||
| 653 | |a anaerobic bacteria | ||
| 653 | |a HSV2 | ||
| 653 | |a bacteriocins | ||
| 653 | |a methotrexate | ||
| 653 | |a microbial interactions | ||
| 653 | |a T cells | ||
| 653 | |a virus | ||
| 653 | |a mice | ||
| 653 | |a lymphoid malignancies | ||
| 653 | |a HPV | ||
| 653 | |a macrophages | ||
| 653 | |a anti-TNF-? | ||
| 653 | |a inflammation | ||
| 653 | |a chondroitin sulfate disaccharide | ||
| 653 | |a immunotherapy | ||
| 653 | |a genomics | ||
| 653 | |a immuno-oncology | ||
| 653 | |a diet | ||
| 653 | |a aerobic bacteria | ||
| 653 | |a immunological niche | ||
| 653 | |a melanin | ||
| 653 | |a health | ||
| 653 | |a chemokines | ||
| 653 | |a gut microbiota | ||
| 653 | |a cutaneous immunity | ||
| 653 | |a HIV | ||
| 653 | |a TIL | ||
| 653 | |a cancer | ||
| 653 | |a global network | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/1778 |7 0 |z Get Fullteks |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/50545 |7 0 |z DOAB: description of the publication |